1. Eteisvärinä Käypä Hoito –suositus, 2017. (www.kaypahoito.fi, viitattu 1/2019)
2. Camm ym. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429. [PubMed: 20802247]
3. Marevan (varfariini). Summary of Product Characteristics
4. Pradaxa (dabigatran) Summary of Product Characteristics
5. Xarelto (rivaroxaban) Summary of Product Characteristics
6. Eliquis (apixaban) Summary of Product Characteristics
7. Lixiana (edoxaban) Summary of Product Characteristics
MLR PC-SE-100625 Jan 2020 - Boehringer Ingelheim Sweden AB